Kempen completes direct private equity investment in British healthcare services company
Since 1983, AJM Healthcare has been a provider of mobility and equipment solutions to the NHS, Local Authority Partners and individuals across the UK. AJM is a leading integrated wheelchair service provider for the NHS, delivering services to a population base of over 2 million and was the first company in the UK to be granted CECOPS accreditation for integrated wheelchair services, widely acknowledged as the gold standard for quality in the sector. AJM employs over 150 people ranging from specialised therapists to field service engineers. In addition, AJM has a commercial servicing division offering a full range of maintenance, service and the supply of mobility and independence solutions equipment direct to customers.
Marvin de Jong, Director Private Markets at Kempen, comments: ‘This direct private equity investment is a valuable additional investment for our diversified Kempen Private Markets Fund. We are very enthusiastic about this deal and the great prospects of this company, specifically in the UK market. We anticipate that AJM’s sector will show strong sustained growth over the short and medium term. We are looking forward to partnering with WestBridge on this and other investments in the years to come.’
Guy Davies, managing partner at WestBridge Capital, said: ‘Weare delighted that Kempen has chosen WestBridge as its UK private equity investment partner and that they are co-investing in AJM Healthcare. We look forward to working with them on other transactions in the future.’
Kempen Private Markets Fund (the Sub-Fund) is a sub-fund of Kempen Alternative Markets Fund Sicav (the “Fund”), domiciled in Luxembourg. Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Sub-Fund is registered under the license of the Fund at The Netherlands Authority for the Financial Markets and not subject to Luxembourg supervision. The information in this document provides insufficient information for an investment decision. Please read the prospectus and the Essential information Document. These documents of the Sub-Fund are available on the website of KCM (www.kempen.com/investmentfunds).
The Sub-Fund is registered for offering in a limited number of countries. The countries where the Sub-Fund is registered can be found on the website. The value of your investment may fluctuate. Past performance provides no guarantee for the future. The Fund is only available for professional investors and well-informed investors.